Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: New Constructs, LLC

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Gilead Sciences Inc Raises FY 2012 Product Sales Guidance-Conference Call

Tuesday, 23 Oct 2012 04:15pm EDT 

Gilead Sciences Inc announced that given the strong year-to-date commercial performance, the Company is increasing product sales guidance for fiscal 2012 to $9.1 billion to $9.2 billion, which represents a $200 million increase from the top end of its previous guidance range. 

Company Quote

0.2 +0.19%
10:20am EDT